lanatoside-c and Heart-Diseases

lanatoside-c has been researched along with Heart-Diseases* in 15 studies

Other Studies

15 other study(ies) available for lanatoside-c and Heart-Diseases

ArticleYear
Effects of crotoxin on the isolated guinea pig heart.
    Toxicon : official journal of the International Society on Toxinology, 1990, Volume: 28, Issue:2

    The effects of crotoxin, isolated from the venom of the South American rattlesnake, Crotalus durissus terrificus, were investigated on isolated guinea pig hearts, perfused with Locke solution, by the Langendorff method. The cardiac beats and the electrocardiogram were simultaneously registered and the creatine kinase (CK) activity of the perfusate measured. Crotoxin was infused (4.5 x 10(-8) M and 2.3 x 10(-7) M) into the heart during 90 min, and induced a remarkable decrease in the contractile force, without a significant reduction of heart rate, increased the P-R interval and displaced the S-T segment. The activity of CK only increased in the late phases of the experiments, when the force of contraction was below 25% of the control value. Arrhythmias were uncommon and no alterations of QRS duration or Q-Tc interval were observed. The reduction of the contractile force and the increase in CK activity were completely prevented by bovine serum albumin, whereas lanatoside C did not interfere with the toxin action. A bolus injection of crotoxin (11 +/- 2 nmoles) also induced a decrease of contractile force without reduction of heart rate. This decrease of force was partially prevented by indomethacin, but not by atropine. It is suggested that the reduction of contractile force evoked by crotoxin is due probably to release of free fatty acids and lysophospholipids (initial effect) and to a cellular lesion (late effect).

    Topics: Albumins; Animals; Atropine; Creatine Kinase; Crotalid Venoms; Crotoxin; Electrocardiography; Fatty Acids, Nonesterified; Female; Guinea Pigs; Heart; Heart Diseases; Heart Rate; In Vitro Techniques; Indomethacin; Lanatosides; Lysophospholipids; Male; Myocardial Contraction; Myocardium

1990
[Treatment of cardiac insufficiency with lanatigen C].
    Vutreshni bolesti, 1979, Volume: 18, Issue:3

    Topics: Administration, Oral; Adult; Aged; Coronary Disease; Female; Heart Defects, Congenital; Heart Diseases; Humans; Hypertension; Lanatosides; Male; Middle Aged; Pulmonary Heart Disease; Rheumatic Heart Disease; Time Factors

1979
[RESULTS OF A CARDIOTONIC THERAPY WITH DESACETYL-LANATOSIDE C].
    Minerva medica, 1965, Apr-04, Volume: 56

    Topics: Cardiotonic Agents; Deslanoside; Geriatrics; Heart Diseases; Humans; Lanatosides

1965
[HEART THERAPY WITH LANATOSIDE C, THEOPHYLLINE AND VITAMIN B FACTORS].
    Deutsches medizinisches Journal, 1964, Feb-20, Volume: 15

    Topics: Diuretics; Folic Acid; Heart Diseases; Humans; Lanatosides; Theophylline; Vitamin B Complex; Vitamins

1964
[CLINICAL EXPERIENCE WITH A NEW CARDIOACTIVE GLYCOSIDE: DESACETYL-LANATOSIDE C].
    La Clinica terapeutica, 1964, Mar-31, Volume: 28

    Topics: Adolescent; Cardiac Glycosides; Deslanoside; Geriatrics; Glycosides; Heart Diseases; Humans; Lanatosides

1964
[ON THE USE OF DESACETYL-LANATOSIDE C IN THE TREATMENT OF CARDIAC INSUFFICIENCY].
    Gazzetta medica italiana, 1964, Volume: 123

    Topics: Adolescent; Biomedical Research; Deslanoside; Geriatrics; Heart Diseases; Heart Failure; Humans; Lanatosides; Toxicology

1964
Effects of lanatoside C on cardiovascular hemodynamics; acute digitalizing doses in subjects with normal hearts and with heart disease without failure.
    The American journal of cardiology, 1959, Volume: 4, Issue:1

    Topics: Digitalis; Heart; Heart Diseases; Hemodynamics; Humans; Lanatosides

1959
[Role of lanatoside C in current heart therapy].
    Medizinische Klinik, 1958, Apr-18, Volume: 53, Issue:16

    Topics: Anti-Arrhythmia Agents; Digitalis; Disease; Heart; Heart Diseases; Humans; Lanatosides; Pancreas; Pancreatic Diseases

1958
[Cardiopulmonary hemodynamic behavior after intravenous administration of lanatoside C in mitral valve disease].
    Minerva medica, 1957, Apr-21, Volume: 48, Issue:32

    Topics: Administration, Intravenous; Chronic Disease; Digitalis; Disease; Heart Diseases; Hemodynamics; Humans; Lanatosides; Mitral Valve

1957
Studies of the renal circulation and renal function in mitral valvular disease. IV. The effect of a single intravenous injection of lanatoside C.
    Cardiologia, 1956, Volume: 29, Issue:5

    Topics: Digitalis; Disease; Heart Diseases; Heart Valve Diseases; Humans; Injections, Intravenous; Kidney; Lanatosides; Mitral Valve; Renal Circulation

1956
[Comparative research on the effect of strophantin and cedilanid on the dynamics of the injured heart muscle in typhoid diseases].
    Wiener klinische Wochenschrift, 1956, Oct-26, Volume: 68, Issue:43

    Topics: Digitalis; Heart Diseases; Lanatosides; Myocardium; Strophanthins; Typhoid Fever

1956
[Lanatoside C, ther. of heart disease in pregnancy].
    Minerva ginecologica, 1954, Apr-30, Volume: 6, Issue:8

    Topics: Digitalis; Female; Heart Diseases; Humans; Lanatosides; Plant Extracts; Pregnancy

1954
[Intravenous use of cedilanid].
    Rassegna internazionale di clinica e terapia, 1953, Jan-31, Volume: 33, Issue:2

    Topics: Cardiotonic Agents; Digitalis; Digitalis Glycosides; Heart Diseases; Lanatosides

1953
[Clinical investigations with cedilanid].
    Cardiologia, 1952, Volume: 22, Issue:Suppl

    Topics: Digitalis; Digitalis Glycosides; Heart Diseases; Lanatosides; Plant Extracts

1952
Studies on the circulation in man; the effect of cedilanid (lanatoside C) on cardiac output and blood pressure in the pulmonary circulation in patients with compensated and decompensated heart disease.
    Acta cardiologica, 1949, Volume: 4, Issue:1

    Topics: Blood Circulation; Blood Pressure; Cardiac Output; Heart Diseases; Humans; Lanatosides; Male; Pulmonary Circulation

1949